395 related articles for article (PubMed ID: 28931523)
1. Contribution of myo-inositol oxygenase in AGE:RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy.
Sharma I; Tupe RS; Wallner AK; Kanwar YS
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F107-F121. PubMed ID: 28931523
[TBL] [Abstract][Full Text] [Related]
2. myo-Inositol Oxygenase Overexpression Accentuates Generation of Reactive Oxygen Species and Exacerbates Cellular Injury following High Glucose Ambience: A NEW MECHANISM RELEVANT TO THE PATHOGENESIS OF DIABETIC NEPHROPATHY.
Sun L; Dutta RK; Xie P; Kanwar YS
J Biol Chem; 2016 Mar; 291(11):5688-5707. PubMed ID: 26792859
[TBL] [Abstract][Full Text] [Related]
3. Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis.
Xie P; Sun L; Oates PJ; Srivastava SK; Kanwar YS
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1393-404. PubMed ID: 20335317
[TBL] [Abstract][Full Text] [Related]
4. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS
Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES.
Tominaga T; Dutta RK; Joladarashi D; Doi T; Reddy JK; Kanwar YS
J Biol Chem; 2016 Jan; 291(3):1348-67. PubMed ID: 26578517
[TBL] [Abstract][Full Text] [Related]
6.
Sharma I; Deng F; Liao Y; Kanwar YS
Diabetes; 2020 Jun; 69(6):1248-1263. PubMed ID: 32169892
[TBL] [Abstract][Full Text] [Related]
7. Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease.
Zhan M; Usman IM; Sun L; Kanwar YS
J Am Soc Nephrol; 2015 Jun; 26(6):1304-21. PubMed ID: 25270067
[TBL] [Abstract][Full Text] [Related]
8. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of myo-inositol oxygenase is involved in the tubulointerstitial injury of diabetic nephropathy.
Lu Y; Liu C; Miao X; Xu K; Wu X; Liu C
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):257-65. PubMed ID: 19053028
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic role of Syzygium cumini (L.) Skeels in glycation induced diabetic nephropathy via RAGE-NF-κB pathway and extracellular proteins modifications: A molecular approach.
Apte MM; Khattar E; Tupe RS
J Ethnopharmacol; 2024 Mar; 322():117573. PubMed ID: 38110133
[TBL] [Abstract][Full Text] [Related]
11. Myo-inositol oxygenase accentuates renal tubular injury initiated by endoplasmic reticulum stress.
Tominaga T; Sharma I; Fujita Y; Doi T; Wallner AK; Kanwar YS
Am J Physiol Renal Physiol; 2019 Feb; 316(2):F301-F315. PubMed ID: 30539651
[TBL] [Abstract][Full Text] [Related]
12. High Glucose-Induced Hypomethylation Promotes Binding of Sp-1 to Myo-Inositol Oxygenase: Implication in the Pathobiology of Diabetic Tubulopathy.
Sharma I; Dutta RK; Singh NK; Kanwar YS
Am J Pathol; 2017 Apr; 187(4):724-739. PubMed ID: 28208054
[TBL] [Abstract][Full Text] [Related]
13. Modulation of gentamicin-induced acute kidney injury by myo-inositol oxygenase via the ROS/ALOX-12/12-HETE/GPR31 signaling pathway.
Sharma I; Liao Y; Zheng X; Kanwar YS
JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315361
[TBL] [Abstract][Full Text] [Related]
14. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions.
Sanajou D; Ghorbani Haghjo A; Argani H; Aslani S
Eur J Pharmacol; 2018 Aug; 833():158-164. PubMed ID: 29883668
[TBL] [Abstract][Full Text] [Related]
15. The Kidney Specific Protein myo-Inositol Oxygenase, a Potential Biomarker for Diabetic Nephropathy.
Gao P; Xu B; Song P; Zhu X; Yuan S; Kanwar YS; Sun L
Kidney Blood Press Res; 2018; 43(6):1772-1785. PubMed ID: 30504713
[TBL] [Abstract][Full Text] [Related]
16. Beneficial Effects of
Dutta RK; Kondeti VK; Sharma I; Chandel NS; Quaggin SE; Kanwar YS
J Am Soc Nephrol; 2017 May; 28(5):1421-1436. PubMed ID: 27895157
[TBL] [Abstract][Full Text] [Related]
17. The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway.
An X; Zhang L; Yao Q; Li L; Wang B; Zhang J; He M; Zhang J
Mol Cell Endocrinol; 2018 Jul; 470():14-25. PubMed ID: 28478303
[TBL] [Abstract][Full Text] [Related]
18. Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis.
Maeda S; Matsui T; Takeuchi M; Yoshida Y; Yamakawa R; Fukami K; Yamagishi S
Pharmacol Res; 2011 Mar; 63(3):241-8. PubMed ID: 21115116
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
